We are live on ! Find out more
NMC

Nine Masts Capital Portfolio holdings

AUM $995M
1-Year Est. Return 22.79%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+22.79%
3 Year Est. Return
+88.15%
5 Year Est. Return
+47.84%
10 Year Est. Return
+90.58%
AUM
$995M
AUM Growth
+$302M
Cap. Flow
+$55.8M
Cap. Flow %
5.61%
Top 10 Hldgs %
72.43%
Holding
311
New
63
Increased
15
Reduced
79
Closed
141

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$299M
2
HDB icon
HDFC Bank
HDB
+$50.2M
3
BCS icon
Barclays
BCS
+$11.9M
4
ROKU icon
Roku
ROKU
+$10.1M
5
KVUE icon
Kenvue
KVUE
+$7.84M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$82.5M
2
ASX icon
ASE Group
ASX
+$20.8M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$19.1M
4
HOLX
Hologic
HOLX
+$17M
5
CWAN
Clearwater Analytics
CWAN
+$13.8M

Sector Composition

Rank Sector Weight
1 Miscellaneous 59.5%
2 Financials 14.37%
3 Communication Services 10.05%
4 Technology 4.56%
5 Industrials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TEAD
251
Teads Holding Co
TEAD
$49.4M
– –
-46,639
Closed -$30.7K
OCGN icon
252
Ocugen
OCGN
$461M
– –
-21,938
Closed -$39.7K
ACH
253
Accendra Health
ACH
$93.1M
– –
-22,373
Closed -$51K
ONL
254
Orion Office REIT
ONL
$155M
– –
-15,823
Closed -$34K
OTLK icon
255
Outlook Therapeutics
OTLK
$162M
– –
-232,546
Closed -$47.9K
PDSB icon
256
PDS Biotechnology
PDSB
$12.3M
– –
-67,507
Closed -$40.8K
PFE icon
257
PUT
Pfizer
PFE
$162B
– –
-88,000
Closed -$43.6K
PGEN icon
258
Precigen
PGEN
$2.54B
– –
-11,608
Closed -$44.9K
PIII icon
259
P3 Health Partners
PIII
$36.6M
– –
-17,964
Closed -$55.3K
PLTK icon
260
Playtika
PLTK
$839M
– –
-10,294
Closed -$28.6K
PRLD icon
261
Prelude Therapeutics
PRLD
$436M
– –
-11,699
Closed -$40K
PRQR icon
262
ProQR Therapeutics
PRQR
$292M
– –
-29,518
Closed -$47.8K
PSQH icon
263
PSQ Holdings
PSQH
$20.5M
– –
-3,512
Closed -$27.9K
QQQ icon
264
Invesco QQQ Trust
QQQ
$490B
– –
-33,106
Closed -$19.1M
QSI icon
265
Quantum-Si Incorporated
QSI
$168M
– –
-41,134
Closed -$31.8K
RANI icon
266
Rani Therapeutics
RANI
$99.9M
– –
-44,849
Closed -$33K
RBBN icon
267
Ribbon Communications
RBBN
$356M
– –
-14,377
Closed -$30.5K
LNAI
268
Lunai Bioworks
LNAI
$10.8M
– –
-12,803
Closed -$41.7K
RVMD icon
269
Revolution Medicines
RVMD
$45B
– –
-11,010
Closed -$1.07M
RVMD icon
270
PUT
Revolution Medicines
RVMD
$45B
– –
-11,000
Closed -$107K
RXT icon
271
Rackspace Technology
RXT
$813M
– –
-23,381
Closed -$22.9K
FLNA
272
Filana Therapeutics
FLNA
$39.6M
– –
-27,107
Closed -$45.8K
SEE
273
CALL
DELISTED
Sealed Air
SEE
– –
-50,000
Closed -$1.25K
SGMO
274
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
– –
-113,465
Closed -$28K
SHEL icon
275
CALL
Shell
SHEL
$266B
– –
-6,300
Closed -$155K
9 10
11
12 13

Similar funds

RBC
Romano Brothers & Co Evanston, Illinois $994M AUM 41.36% 1-Year Est. Return
SFA
Souders Financial Advisors Cincinnati, Ohio $994M AUM 18.44% 1-Year Est. Return
LG
Leuthold Group Minneapolis, Minnesota $995M AUM 44.2% 1-Year Est. Return
AGDI
Absolute Gestao de Investimentos Sao Paulo, Brazil $994M AUM 54.06% 1-Year Est. Return
RCG
Rock Creek Group Washington, District of Columbia $994M AUM 11.29% 1-Year Est. Return
PAI
Power Alpha Investment Road Town, Tortola, British Virgin Islands $994M AUM
HWA
HHM Wealth Advisors Chattanooga, Tennessee $996M AUM 23.11% 1-Year Est. Return
DA
Denali Advisors San Diego, California $993M AUM 34.77% 1-Year Est. Return

Nine Masts Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Nine Masts Capital held 311 positions worth $995M, up 44% from $693M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Nine Masts Capital deployed $55.8M of net new capital in Q2 2026, opening 63 new positions and adding to 15 existing holdings. Its largest new stake was Barclays: 493,965 shares worth $13.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 59% of assets, up from 38% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $82.5M trimmed.

  • Nine Masts Capital's largest Q2 2026 buy was Barclays: 493,965 shares worth $13.3M.
  • Nine Masts Capital added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $299M increase.
  • Nine Masts Capital's biggest Q2 2026 reduction was Alphabet (Google) Class C, cutting an estimated $82.5M.
  • Nine Masts Capital fully exited Invesco QQQ Trust in Q2 2026, selling an estimated $19.1M.
  • Nine Masts Capital's ten largest holdings make up 72% of its $995M portfolio in Q2 2026.
  • Nine Masts Capital opened 63 new positions and closed 141 in Q2 2026.
  • Nine Masts Capital's portfolio value rose 44% quarter-over-quarter to $995M.

Based on Nine Masts Capital's 13F filing for Q2 2026, filed 7 Aug 2026.